- Home
- ANVS vs GOAI Comparison
ANVS vs GOAI Comparison
Compare ANVS & GOAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANVS | GOAI |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | United States |
| Employees | N/A | 3 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.6M | 83.5M |
| IPO Year | 2019 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ANVS | GOAI |
|---|---|---|
| Price | $1.82 | $2.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 590.2K | 94.5K |
| Earning Date | 05-12-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 39.39 | ★ 966.67 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $17,037,328.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 82.59 |
| 52 Week Low | $1.54 | $1.42 |
| 52 Week High | $5.50 | $6.67 |
Technical Indicators
Market Signals| Indicator | ANVS | GOAI |
|---|---|---|
| Relative Strength Index (RSI) | 48.27 | 62.32 |
| Support Level | $1.73 | $2.07 |
| Resistance Level | $2.02 | $2.68 |
| Average True Range (ATR) | 0.10 | 0.19 |
| MACD | -0.00 | 0.08 |
| Stochastic Oscillator | 25.39 | 85.87 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
About GOAI Eva Live Inc. Common Stock
Eva Live Inc is a United States-based technology company that has developed an automated and intelligent advertiser campaign management platform, Eva Platform, which enables advertisers ('customers, clients') to buy advertising space on several digital channels to reach their desired audience. The company also works with Businesses that utilize its in-house digital marketing capabilities, including advice, creative services, account management, production of advertising materials, media planning, and buying.